Search research articles
Contact Us
Filters
Showing results (1-10 of 27) with videos related to
Page
of 3
Sort By:
Blood
|
May 14, 2026
Pruning the Waldenström macroglobulinemia evolutionary tree
Patrick Blaney, Gareth J Morgan
Blood
|
February 27, 2026
Study of NSD2 using a dTAG system reveals their molecular mechanism and oncogenic implications in t(4;14) multiple myeloma
Yubao Wang, Sanxiong Liu, Hussein Ghamlouch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2023
Impact of Rare Structural Variant Events in Newly Diagnosed Multiple Myeloma
Monika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, et al.
Biorxiv : the Preprint Server for Biology
|
January 30, 2023
Impact of rare structural variant events in newly diagnosed multiple myeloma
Monika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 3, 2021
Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer
Hussein Ghamlouch, Eileen M Boyle, Patrick Blaney, et al.
Experimental Hematology & Oncology
|
February 26, 2025
A proinflammatory response and polarized differentiation of stromal elements characterizes the murine myeloma bone marrow niche
Hussein Ghamlouch, Dylan C Gagler, Patrick Blaney, et al.
Scientific Reports
|
October 19, 2018
Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene
Christopher R Clark, Makayla Maile, Patrick Blaney, et al.
Research Square
|
August 30, 2023
Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myeloma
Travis S Johnson, Parvathi Sudha, Enze Liu, et al.
Bioinformatics (Oxford, England)
|
July 8, 2025
AncestryGeni: a novel genetic ancestry classification pipeline for small and noisy sequence data
Eran Elhaik, Sara Behnamian, Michael Howe, et al.
Nature Communications
|
May 16, 2024
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma
Travis S Johnson, Parvathi Sudha, Enze Liu, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 27) with videos related to
Sort By:
Page
of 3
Blood
|
May 14, 2026
Pruning the Waldenström macroglobulinemia evolutionary tree
Patrick Blaney, Gareth J Morgan
Blood
|
February 27, 2026
Study of NSD2 using a dTAG system reveals their molecular mechanism and oncogenic implications in t(4;14) multiple myeloma
Yubao Wang, Sanxiong Liu, Hussein Ghamlouch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 8, 2023
Impact of Rare Structural Variant Events in Newly Diagnosed Multiple Myeloma
Monika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, et al.
Biorxiv : the Preprint Server for Biology
|
January 30, 2023
Impact of rare structural variant events in newly diagnosed multiple myeloma
Monika Chojnacka, Benjamin Diamond, Bachisio Ziccheddu, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
December 3, 2021
Insights into high-risk multiple myeloma from an analysis of the role of PHF19 in cancer
Hussein Ghamlouch, Eileen M Boyle, Patrick Blaney, et al.
Experimental Hematology & Oncology
|
February 26, 2025
A proinflammatory response and polarized differentiation of stromal elements characterizes the murine myeloma bone marrow niche
Hussein Ghamlouch, Dylan C Gagler, Patrick Blaney, et al.
Scientific Reports
|
October 19, 2018
Transposon mutagenesis screen in mice identifies TM9SF2 as a novel colorectal cancer oncogene
Christopher R Clark, Makayla Maile, Patrick Blaney, et al.
Research Square
|
August 30, 2023
Identifying 1q amplification and PHF19 expressing high-risk cells associated with relapsed/refractory multiple myeloma
Travis S Johnson, Parvathi Sudha, Enze Liu, et al.
Bioinformatics (Oxford, England)
|
July 8, 2025
AncestryGeni: a novel genetic ancestry classification pipeline for small and noisy sequence data
Eran Elhaik, Sara Behnamian, Michael Howe, et al.
Nature Communications
|
May 16, 2024
1q amplification and PHF19 expressing high-risk cells are associated with relapsed/refractory multiple myeloma
Travis S Johnson, Parvathi Sudha, Enze Liu, et al.
Page
of 3